Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.636
-0.314 (-10.63%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cyclerion Therapeutics Employees
Cyclerion Therapeutics had 1 employees as of December 31, 2023. The number of employees decreased by 15 or -93.75% compared to the previous year.
Employees
1
Change (1Y)
-15
Growth (1Y)
-93.75%
Revenue / Employee
n/a
Profits / Employee
$3,008,000
Market Cap
6.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Syra Health | 162 |
Zhongchao | 142 |
Vaccinex | 40 |
Viracta Therapeutics | 40 |
Healthcare Triangle | 31 |
Genprex | 26 |
Organovo Holdings | 20 |
Galecto | 13 |
CYCN News
- 3 months ago - Regina Graul, Ph.D., Promoted to Chief Executive Officer - GlobeNewsWire
- 1 year ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire
- 1 year ago - Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - GlobeNewsWire
- 1 year ago - Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - GlobeNewsWire
- 1 year ago - Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 1 year ago - Cyclerion Announces Reverse Stock Split - GlobeNewsWire
- 1 year ago - Cyclerion Announces Definitive Agreement for Zagociguat and CY3018 - GlobeNewsWire
- 1 year ago - Cyclerion Announces Corporate Updates and Q1 2023 Financial Results - GlobeNewsWire